Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep F Nomdedeu

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Blood|September 30, 2021
CEBPA bZip mutations: just a single shotJorge Sierra, Josep F Nomdedeu
Blood|November 16, 2002
ETO sequence may be dispensable in some AML1-ETO leukemiasAdriana Lasa, Josep F Nomdedeu, Maria J Carnicer, et al.
Haematologica|September 8, 2006
A new D816 c-KIT gene mutation in refractory AML1-ETO leukemiaAdriana Lasa, Maria T Carricondo, Maria J Carnicer, et al.
Journal of the American Academy of Dermatology|July 26, 2002
Invisible mycosis fungoides: a diagnostic challengeRamon M Pujol, Fernando Gallardo, Enric Llistosella, et al.
The Journal of Dermatology|December 13, 2005
Peripheral T-cell lymphoma with secondary epithelioid granulomatous cutaneous involvement: a clinicopathologic study of four casesRamon M Pujol, Fernando Gallardo, Octavio Servitje, et al.
Thrombosis Research|July 8, 2015
Genetic determinants of platelet large-cell ratio, immature platelet fraction, and other platelet-related phenotypesNúria Pujol-Moix, Miquel Vázquez-Santiago, Agnès Morera, et al.
Annals of Hematology|July 1, 2008
K313dup is a recurrent CEBPA mutation in de novo acute myeloid leukemia (AML)Maria J Carnicer, Adriana Lasa, Marcus Buschbeck, et al.
Scientific Reports|July 10, 2024
Author Correction: Titers of IgG and IgA against SARS-CoV-2 proteins and their association with symptoms in mild COVID-19 infectionAndrés G Abril, Jose Alejandre, Anais Mariscal, et al.
Annals of Hematology|March 2, 2021
The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patientsWilliam G Dunn, Muxin S Gu, Margarete A Fabre, et al.
Scientific Reports|June 3, 2024
Titers of IgG and IgA against SARS-CoV-2 proteins and their association with symptoms in mild COVID-19 infectionAndrés G Abril, Jose Alejandre, Anais Mariscal, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Blood|September 30, 2021
CEBPA bZip mutations: just a single shotJorge Sierra, Josep F Nomdedeu
Blood|November 16, 2002
ETO sequence may be dispensable in some AML1-ETO leukemiasAdriana Lasa, Josep F Nomdedeu, Maria J Carnicer, et al.
Haematologica|September 8, 2006
A new D816 c-KIT gene mutation in refractory AML1-ETO leukemiaAdriana Lasa, Maria T Carricondo, Maria J Carnicer, et al.
Journal of the American Academy of Dermatology|July 26, 2002
Invisible mycosis fungoides: a diagnostic challengeRamon M Pujol, Fernando Gallardo, Enric Llistosella, et al.
The Journal of Dermatology|December 13, 2005
Peripheral T-cell lymphoma with secondary epithelioid granulomatous cutaneous involvement: a clinicopathologic study of four casesRamon M Pujol, Fernando Gallardo, Octavio Servitje, et al.
Thrombosis Research|July 8, 2015
Genetic determinants of platelet large-cell ratio, immature platelet fraction, and other platelet-related phenotypesNúria Pujol-Moix, Miquel Vázquez-Santiago, Agnès Morera, et al.
Annals of Hematology|July 1, 2008
K313dup is a recurrent CEBPA mutation in de novo acute myeloid leukemia (AML)Maria J Carnicer, Adriana Lasa, Marcus Buschbeck, et al.
Scientific Reports|July 10, 2024
Author Correction: Titers of IgG and IgA against SARS-CoV-2 proteins and their association with symptoms in mild COVID-19 infectionAndrés G Abril, Jose Alejandre, Anais Mariscal, et al.
Annals of Hematology|March 2, 2021
The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patientsWilliam G Dunn, Muxin S Gu, Margarete A Fabre, et al.
Scientific Reports|June 3, 2024
Titers of IgG and IgA against SARS-CoV-2 proteins and their association with symptoms in mild COVID-19 infectionAndrés G Abril, Jose Alejandre, Anais Mariscal, et al.
Pageof 3